PT - JOURNAL ARTICLE AU - T D Dobbs AU - J A G Gibson AU - A J Fowler AU - T E Abbott AU - T Shahid AU - F Torabi AU - R Griffiths AU - R A Lyons AU - R M Pearse AU - I S Whitaker TI - Surgical activity in England and Wales during the COVID-19 pandemic: a nationwide observational cohort study AID - 10.1101/2021.02.27.21252593 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.27.21252593 4099 - http://medrxiv.org/content/early/2021/03/01/2021.02.27.21252593.short 4100 - http://medrxiv.org/content/early/2021/03/01/2021.02.27.21252593.full AB - Objectives To report the volume of surgical activity and the number of cancelled surgical procedures during the COVID-19 pandemic.Design and setting Analysis of electronic health record data from the National Health Service (NHS) in England and Wales.Methods We used hospital episode statistics for all adult patients undergoing surgery between 1st January 2020 and 31st December 2020. We identified surgical procedures using a previously published list of procedure codes. Procedures were stratified by urgency of surgery as defined by NHS England. We calculated the deficit of surgical activity by comparing the expected number of procedures from the years 2016-2019 with the actual number of procedures in 2020. We estimated the cumulative number of cancelled procedures by 31st December 2021 according patterns of activity in 2020.Results The total number of surgical procedures carried out in England and Wales in 2020 was 3,102,674 compared to the predicted number of 4,671,338. This represents a 33.6% reduction in the national volume of surgical activity. There were 763,730 emergency surgical procedures (13.4% reduction), compared to 2,338,944 elective surgical procedures (38.6% reduction). The cumulative number of cancelled or postponed procedures was 1,568,664. We estimate that this will increase to 2,358,420 by 31st December 2021.Conclusions The volume of surgical activity in England and Wales was reduced by 33.6% in 2020, resulting in over 1,568,664 cancelled operations. This deficit will continue to grow in 2021.What is already known on this topicThe COVID-19 pandemic necessitated a rapid change in the provision of care, including the suspension of a large proportion of surgical activitySurgical activity has yet to return to normal and has been further impacted by subsequent waves of the pandemicThis will lead to a large backlog of casesWhat this study adds3,102,674 surgical procedures were performed in England and Wales during 2020, a 33.6% reduction on the expected yearly surgical activityOver 1.5 million procedures were not performed, with this deficit likely to continue to grow to 2.3 million by the end of 2021This deficit is the equivalent of more than 6 months of pre-pandemic surgical activity, requiring a monumental financial and logistic challenge to manageCompeting Interest StatementAll authors have completed the Unified Competing Interest form and declare: AJF holds a National Institute for Health Research Doctoral Research fellowship (DRF-2018-11-ST2-062). TDD reports funding from the Welsh Clinical Academic Training (WCAT) Fellowship. IW reports active grants from the American Association of Plastic Surgeons and the European Association of Plastic Surgeons; is an editor for Frontiers of Surgery, associate editor for the Annals of Plastic Surgery, editorial board of BMC Medicine and numerous other editorial board roles. RP has received honoraria and/or research grants from Edwards Lifesciences, Intersurgical and GlaxoSmithkline within the last five years and holds editorial roles with the British Journal of Anaesthesia, the British Journal of Surgery and BMJ Quality and Safety. TA is a member of the associate editorial board of the British Journal of Anaesthesia and has received consultancy fees from MSD unrelated to this work. All other authors report no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.Funding StatementThis study was funded by a grant from Barts Charity. The Welsh data source was supported by Health Data Research UK, which receives its funding from HDR UK Ltd (HDR-9006) funded by the UK Medical Research Council (MRC), Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation (BHF) and the Wellcome Trust. The study was also supported by a separate grant from the MRC (MR/V028367/1). The funding sources had no role in the study design, data collection, analysis, interpretation, or writing the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All research conducted has been completed under the permission and approval of the SAIL independent Information Governance Review Panel (IGRP) project number 0911.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study are derived from two data sources. It is not possible to share the raw patient-level data provided by NHS Digital describing NHS patients in England. Regarding data from NHS patients in Wales, the data used are available in the SAIL Databank at Swansea University, Swansea, UK, but as restrictions apply they are not publicly available. All proposals to use SAIL data are subject to review by an independent Information Governance Review Panel (IGRP). Before any data can be accessed, approval must be given by the IGRP. The IGRP gives careful consideration to each project to ensure proper and appropriate use of SAIL data. When access has been granted, it is gained through a privacy protecting safe haven and remote access system referred to as the SAIL Gateway. SAIL has established an application process to be followed by anyone who would like to access data via SAIL at https://www.saildatabank.com/application-process.